These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37696679)

  • 1. Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial.
    Kongkam P; Khongkha W; Lopimpisuth C; Chumsri C; Kosarussawadee P; Phutrakool P; Khamsai S; Sawanyawisuth K; Sura T; Phisalprapa P; Buamahakul T; Siwamogsatham S; Angsusing J; Poonniam P; Wanaratna K; Teerachaisakul M; Pongpirul K
    BMJ Evid Based Med; 2023 Nov; 28(6):399-406. PubMed ID: 37696679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcuma longa Linn versus omeprazole in treatment of functional dyspepsia: A randomized, double-blind, placebo-controlled trial.
    Yongwatana K; Harinwan K; Chirapongsathorn S; Opuchar K; Sanpajit T; Piyanirun W; Puttapitakpong C
    J Gastroenterol Hepatol; 2022 Feb; 37(2):335-341. PubMed ID: 34652861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia.
    Rabeneck L; Souchek J; Wristers K; Menke T; Ambriz E; Huang I; Wray N
    Am J Gastroenterol; 2002 Dec; 97(12):3045-51. PubMed ID: 12492188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.
    Vardi M; Cryer BL; Cohen M; Lanas A; Schnitzer TJ; Lapuerta P; Goldsmith MA; Laine L; Doros G; Liu Y; McIntosh AI; Cannon CP; Bhatt DL
    Aliment Pharmacol Ther; 2015 Aug; 42(3):365-74. PubMed ID: 26032114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
    Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial.
    Wauters L; Slaets H; De Paepe K; Ceulemans M; Wetzels S; Geboers K; Toth J; Thys W; Dybajlo R; Walgraeve D; Biessen E; Verbeke K; Tack J; Van de Wiele T; Hellings N; Vanuytsel T
    Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):784-792. PubMed ID: 34358486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.
    Koelz HR; Arnold R; Stolte M; Fischer M; Blum AL;
    Gut; 2003 Jan; 52(1):40-6. PubMed ID: 12477757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia.
    Jones R; Crouch SL
    Aliment Pharmacol Ther; 1999 Mar; 13(3):413-9. PubMed ID: 10102976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT.
    Wilson JA; Stocken DD; Watson GC; Fouweather T; McGlashan J; MacKenzie K; Carding P; Karagama Y; Harries M; Ball S; Khwaja S; Costello D; Wood R; Lecouturier J; O'Hara J
    Health Technol Assess; 2021 Jan; 25(3):1-118. PubMed ID: 33492208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment.
    Manes G; Menchise A; de Nucci C; Balzano A
    BMJ; 2003 May; 326(7399):1118. PubMed ID: 12763982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?
    Bolling-Sternevald E; Lauritsen K; Talley NJ; Junghard O; Glise H
    Aliment Pharmacol Ther; 2003 Jul; 18(1):117-24. PubMed ID: 12848633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).
    Talley NJ; Meineche-Schmidt V; Paré P; Duckworth M; Räisänen P; Pap A; Kordecki H; Schmid V
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1055-65. PubMed ID: 9845395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
    Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
    N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of upper endoscopy on satisfaction in patients with previously uninvestigated dyspepsia.
    Rabeneck L; Wristers K; Souchek J; Ambriz E
    Gastrointest Endosc; 2003 Mar; 57(3):295-9. PubMed ID: 12612505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies.
    Talley NJ; Lauritsen K
    Gut; 2002 May; 50 Suppl 4(Suppl 4):iv36-41. PubMed ID: 11953346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health.
    Rabeneck L; Cook KF; Wristers K; Souchek J; Menke T; Wray NP
    J Clin Epidemiol; 2001 Aug; 54(8):755-65. PubMed ID: 11470383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).
    Sakurai K; Nagahara A; Inoue K; Akiyama J; Mabe K; Suzuki J; Habu Y; Araki A; Suzuki T; Satoh K; Nagami H; Harada R; Tano N; Kusaka M; Fujioka Y; Fujimura T; Shigeto N; Oumi T; Miwa J; Miwa H; Fujimoto K; Kinoshita Y; Haruma K
    BMC Gastroenterol; 2012 May; 12():42. PubMed ID: 22548767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).
    Delaney BC; Qume M; Moayyedi P; Logan RF; Ford AC; Elliott C; McNulty C; Wilson S; Hobbs FD
    BMJ; 2008 Mar; 336(7645):651-4. PubMed ID: 18310262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
    McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T
    N Engl J Med; 1998 Dec; 339(26):1869-74. PubMed ID: 9862941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.